Find uplifting stories about heroes, innovations, and solutions
890 results for "shingles vaccine"
A new study of over 500,000 nursing home residents found that people who received the Shingrix shingles vaccine were 24% less likely to develop dementia. This common vaccine could prevent one in 17 dementia cases while also protecting against painful shingles infections.
A common vaccine designed to prevent shingles may also protect against dementia and Alzheimer's disease. Multiple studies across three countries show vaccinated adults face significantly lower dementia rates.
A USC study of 3,800 older adults found that the shingles vaccine doesn't just prevent disease—it may actually slow biological aging. Vaccinated seniors showed lower inflammation and younger biological profiles than unvaccinated peers.
New research reveals the shingles vaccine does more than prevent painful rashes. Scientists found it may protect against dementia and slow biological aging at the molecular level.
Scientists have identified three medicines already on pharmacy shelves that could help fight Alzheimer's, with a shingles vaccine leading the pack. The discovery could fast-track new treatments by years and save billions in development costs.
A common vaccine given to seniors might do more than prevent shingles. Scientists found it could actually slow down biological aging and reduce the inflammation that drives age-related diseases.
Getting a shingles shot might do more than prevent a painful rash. New research shows it could actually slow down how fast your body ages.
Since the HPV vaccine became available in 2006, cervical cancer rates have dropped 27% among young American women, with some states seeing reductions over 50%. Every 10% increase in vaccination rates translates to nearly 12% fewer cancer cases.
South Carolina's largest measles outbreak in decades has officially ended after nearly 1,000 cases, and there's encouraging news: vaccination rates are climbing both locally and nationwide. Health officials say the outbreak may have reminded parents why vaccines matter.
Scientists at Washington University have created a nose spray vaccine that completely protected mice and hamsters from bird flu infection, offering hope for preventing the next pandemic. The vaccine works better than traditional flu shots and stays effective even in people who've had previous flu vaccines.
The FDA reversed its decision and will now review Moderna's groundbreaking mRNA flu vaccine, marking a potential leap forward in flu prevention. This could bring the same technology that revolutionized COVID vaccines to seasonal flu shots.
California health officials are encouraging at-risk residents to get vaccinated against mpox as case rates have more than quadrupled compared to last year. The vaccine provides strong protection against both strains of the virus, and most new infections are happening in unvaccinated people.
A groundbreaking trial shows Moderna's new mRNA flu vaccine is 27% more effective than traditional flu shots, offering hope for better protection during flu season. The technology's faster production could mean vaccines that better match circulating strains.
African countries have prevented nearly one million cervical cancer deaths through expanded HPV vaccination programs since 2019, while new malaria vaccines are saving thousands of children across 25 nations. These historic health wins are generating $1.8 billion in economic benefits, though funding gaps now threaten to slow the momentum.
Scientists are fast-tracking three promising vaccines to fight the Ebola outbreak in Congo and Uganda, with clinical trials starting within months. New funding of $62 million is speeding up development of the first vaccines specifically designed for the Bundibugyo virus strain.
Iceland, Portugal, and Norway have reached the ambitious target of vaccinating 90% of girls against HPV by age 15, bringing cervical cancer elimination within reach. Since 2020, every European country has reported declining cervical cancer rates among vaccinated women. #
An FDA committee greenlighted next year's flu vaccine formulation this week, maintaining the proven update process while vaccine policy debates swirl in Washington. The decision keeps Americans on track for seasonal flu protection.
South Africa is expanding its lifesaving HPV vaccination campaign to reach every girl in the country, protecting them from cervical cancer that kills over 3,000 women annually. Since 2014, the program has already vaccinated 3.6 million girls with more than 7.2 million doses administered.
After a century with only one TB vaccine, three promising candidates are in final trials, led by South African researchers who could deliver a breakthrough by 2028. The new vaccines could prevent millions of deaths from a disease that still kills over 1.5 million people yearly.
Republican pollsters are finding overwhelming voter support for vaccines and immunization programs, helping to slow aggressive policy changes. New data shows most Americans reject vaccine skepticism and support keeping childhood vaccination recommendations.
Showing 20 of 890